主的悖论和两个网络元分析模型
Yu-Kang Tu1,2, James S Hodges1,3
1Institute of Health Data Analytics & Statistics, College of Public Health, https://ror.org/05bqach95National Taiwan University, Taipei, Taiwan.
Research synthesis methods
|February 2, 2026
概括
在网络元分析 (NMA) 中,基于对比的模型 (CBM) 和基线模型 (BM) 在处理基线效应方面有所不同. 根据CBM和BM之间的结果差异可能表明过渡性假设存在问题.
科学领域:
- 生物统计学 生物统计学
- 医学研究方法学 医学研究方法学
背景情况:
- 网络元分析 (NMA) 通常采用基于对比度的模型 (CBM).
- 像基线模型 (BM) 这样的替代方法的使用较少.
- 了解CBM和BM之间的区别对于准确的NMA解释至关重要.
研究的目的:
- 阐明CBM和BM在NMA中的假设和应用的差异.
- 确定CBM和BM产生不同结果的条件.
- 为了探索这些差异的含义,使用Lord's Paradox的类比.
主要方法:
- 代数和图形分析来比较CBM和BM假设.
- 在NMA模型和Lord's悖论 (t-test与ANCOVA) 之间进行并行.
- 调查基线效应建模对NMA结果的影响.
主要成果:
- CBM将基线结果水平视为固定效应,假设可交换的治疗对比.
- BM将基线结果水平视为随机效应,假设可交换的基线结果.
- CBM和BM之间的差异反映了Lord悖论中的t-test (观察变化) 与ANCOVA (调整变化) 的差异.
结论:
- 选择CBM和BM之间的选择取决于关于基线效应和治疗对比的假设.
- 在CBM和BM结果之间存在重大差异可能表明违反了NMA中的过渡性假设.
- 在解释NMA结果时建议谨慎,特别是当模型产生显著不同的结果时.
相关概念视频
Mechanistic Models: Compartment Models in Individual and Population Analysis
360
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
360
Pharmacokinetic Models: Comparison and Selection Criterion
491
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
491
Pharmacodynamic Models: Overview
161
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
161
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
121
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
121
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
157
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
157
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
149
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A...
149


